Skip to main content

GREENLIGHT CAPITAL RE LTD

For the period ended Sep 30, 2024. Filed Nov 4, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 4, 2024

GLRE$16.13+0.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30, 2024 (unaudited) and December 31, 2023

(expressed in thousands of U.S. dollars, except per share and share amounts)

September 30, 2024December 31, 2023
Assets
Investments
Investment in related party investment fund, at fair value$397,888$258,890
Other investments73,55973,293
Total investments471,447332,183
Cash and cash equivalents54,64251,082
Restricted cash and cash equivalents567,091604,648
Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854)718,719619,401
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $700 and 2023: $487)65,94725,687
Deferred acquisition costs82,20679,956
Unearned premiums ceded35,27017,261
Other assets6,3645,089
Total assets$2,001,686$1,735,307
Liabilities and equity
Liabilities
Loss and loss adjustment expense reserves$811,152$661,554
Unearned premium reserves347,103306,310
Reinsurance balances payable88,15268,983
Funds withheld20,78817,289
Other liabilities8,49111,795
Debt62,58273,281
Total liabilities1,338,2681,139,212
Commitments and Contingencies (Note 15)
Shareholders' equity
Preferred share capital (par value $0.10; none issued)——
Ordinary share capital (par value $0.10; issued and outstanding, 34,832,493) (2023: par value $0.10; issued and outstanding, 35,336,732)3,4833,534
Additional paid-in capital481,672484,532
Retained earnings178,263108,029
Total shareholders' equity663,418596,095
Total liabilities and equity$2,001,686$1,735,307

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the three and nine months ended September 30, 2024 and 2023

(expressed in thousands of U.S. dollars, except per share and share amounts)

Three months ended September 30Nine months ended September 30
2024202320242023
Revenues
Gross premiums written$168,346$183,074$554,579$524,472
Gross premiums ceded(26,598)(14,789)(64,611)(35,740)
Net premiums written141,748168,285489,968488,732
Change in net unearned premium reserves10,136(5,175)(18,150)(43,030)
Net premiums earned151,884163,110471,818445,702
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3)19,844(1,853)42,42227,791
Net investment income8,2446,95824,61124,705
Foreign exchange gains (losses)5,826(1,999)3,2457,661
Other income, net2,21070612,0885,738
Total revenues188,008166,922554,184511,597
Expenses
Net loss and loss adjustment expenses incurred93,16596,843304,524284,072
Acquisition costs46,16246,933138,226126,702
General and administrative expenses10,3267,90531,55727,866
Deposit interest expense3772783,139645
Interest expense2,0181,4574,8272,977
Total expenses152,048153,416482,273442,262
Income before income tax35,96013,50671,91169,335
Income tax expense(723)(29)(1,677)(111)
Net income$35,237$13,477$70,234$69,224
Earnings per share ("EPS"):
Basic$1.03$0.40$2.05$2.03
Diluted$1.01$0.39$2.02$1.99
Weighted average number of ordinary shares used in the determination of EPS:
Basic34,120,95534,070,81834,210,56034,067,012
Diluted34,810,06634,801,86434,824,37234,703,973

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

For the three and nine months ended September 30, 2024 and 2023

(expressed in thousands of U.S. dollars)

Three months ended September 30Nine months ended September 30
2024202320242023
Ordinary share capital
Balance - beginning of period$3,532$3,527$3,534$3,482
Issue of ordinary shares, net of forfeitures67452
Repurchase of ordinary shares(55)—(55)—
Balance - end of period3,4833,5343,4833,534
Additional paid-in capital
Balance - beginning of period487,462480,648484,532478,439
Repurchase of ordinary shares(7,433)—(7,433)—
Share-based compensation expense1,6431,2604,5733,469
Balance - end of period481,672481,908481,672481,908
Retained earnings
Balance - beginning of period143,02676,946108,02921,199
Net income35,23713,47770,23469,224
Balance - end of period178,26390,423178,26390,423
Total shareholders' equity$663,418$575,865$663,418$575,865

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2024 and 2023

(expressed in thousands of U.S. dollars)

Nine months ended September 30
20242023
Cash flows from operating activities
Net income$70,234$69,224
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities:
Income from investments in related party investment fund(42,422)(27,791)
Net realized gain on repurchases of convertible senior notes payable—(265)
Net realized and unrealized losses (gains) on other investments3242,299
Net realized and unrealized losses (gains) on derivatives58—
Current expected credit losses (gains) recognized on reinsurance assets225500
Share-based compensation expense4,5773,521
Accretion of debt offering costs and change in interest accruals1,177(98)
Net change in:
Reinsurance balances receivable(99,329)(135,281)
Loss and loss adjustment expenses recoverable(40,474)(15,007)
Deferred acquisition costs(2,250)(2,711)
Unearned premiums ceded(18,009)(547)
Loss and loss adjustment expense reserves149,598102,766
Unearned premium reserves40,79332,762
Reinsurance balances payable19,169(35,253)
Funds withheld3,499(8,501)
Other items, net(5,200)(248)
Net cash provided by (used in) operating activities81,970(14,630)
Cash flows from investing activities
Proceeds from redemptions of investment in Solasglas14,00073,997
Contributions to investment in Solasglas(110,576)(97,000)
Purchases of other investments(814)(5,545)
Proceeds on disposal of other investments1686,000
Net cash used in investing activities(97,222)(22,548)
Cash flows from financing activities
Proceeds from term loans—74,053
Repayment of term loans(11,876)—
Repayment of convertible senior notes payable—(62,147)
Repurchases of convertible senior notes payable—(17,198)
Repurchase of shares(7,488)—
Net cash used in financing activities(19,364)(5,292)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash619(152)
Decrease in cash, cash equivalents and restricted cash(33,997)(42,622)
Cash, cash equivalents and restricted cash at beginning of the period655,730706,548
Cash, cash equivalents and restricted cash at end of the period$621,733$663,926
Supplementary information
Interest paid in cash$3,825$3,336
Income tax paid (refund received) in cash19256

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2024

  1. ORGANIZATION AND BASIS OF PRESENTATION

Organization

Greenlight Capital Re, Ltd. (“GLRE” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

Basis of Presentation

These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2023 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation.

In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year.

Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars.

Reclassifications

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.

  1. SIGNIFICANT ACCOUNTING POLICIES

There were no material changes to the Company’s significant accounting policies subsequent to its 2023 Form 10-K.

Recently Issued Accounting Standards Not Yet Adopted

On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted.

On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements.

As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.

  1. INVESTMENT IN RELATED PARTY INVESTMENT FUND

Effective August 1, 2024, the Company and Solasglas Investments, LP (“Solasglas”) entered into Amendment No. 2 to the Second Amended and Restated Exempted Limited Partnership Agreement, to revise the Investment Cap from 60% to 70% (as defined in Note 3 of the 2023 Form 10-K).

The Company’s maximum exposure to loss relating to Solasglas is limited to GLRE's share of Partners’ capital in Solasglas. At September 30, 2024, GLRE’s share of Partners’ capital in Solasglas was $397.9 million (December 31, 2023: $258.9 million), representing 77.2% (December 31, 2023:72.7%) of Solasglas’ total net assets. DME Advisors II, LLC held the remaining 22.8% (December 31, 2023:27.3%) of Solasglas’ total net assets.

The Company’s share of the net increase in Partner’s capital for the three and nine months ended September 30, 2024 was $19.8 million and $42.4 million, respectively, (three and nine months ended September 30, 2023: a net decrease of $1.9 million and a net increase of $27.8 million, respectively), as shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP

September 30, 2024December 31, 2023
Assets
Investments, at fair value$549,163$453,358
Derivative contracts, at fair value11,84411,167
Due from brokers210,446121,754
Cash and cash equivalents21,782—
Interest and dividends receivable4381,143
Total assets793,673587,422
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(263,540)(197,571)
Derivative contracts, at fair value(12,101)(12,917)
Capital withdrawals payable(1,250)(1,000)
Due to brokers—(17,398)
Interest and dividends payable(1,409)(2,315)
Accrued expenses and other liabilities(204)(247)
Total liabilities(278,504)(231,448)
Partners' capital$515,170$355,974
GLRE’s share of Partners' capital$397,888$258,890

Summarized Statements of Operations of Solasglas Investments, LP

Three months ended September 30Nine months ended September 30
2024202320242023
Investment income
Dividend income (net of withholding taxes)$752$273$2,524$1,624
Interest income3,5402,52310,0406,415
Total Investment income4,2922,79612,5648,039
Expenses
Management fee(1,613)(1,238)(4,344)(3,469)
Interest(817)(2,380)(2,887)(5,387)
Dividends(782)(659)(2,217)(1,871)
Professional fees and other(262)(507)(921)(1,396)
Total expenses(3,474)(4,784)(10,369)(12,123)
Net investment income (loss)818(1,988)2,195(4,084)
Realized and change in unrealized gains (losses)
Net realized gain (loss)23,64746086,677(2,145)
Net change in unrealized appreciation (depreciation)4,801(1,191)(24,582)52,601
Net gain (loss) on investment transactions28,448(731)62,09550,456
Net increase (decrease) in Partners' capital (1)$29,265$(2,719)$64,289$46,372
GLRE’s share of the increase (decrease) in Partners' capital$19,844$(1,853)$42,422$27,791

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2024202320242023
Management fees$1,613$1,238$4,344$3,469
Performance allocation2,205$(206)4,7143,088
Total$3,818$1,032$9,058$6,557
  1. OTHER INVESTMENTS

At September 30, 2024, the breakdown of the Company’s other investments was as follows:

CostUnrealizedgainsUnrealizedlossesAccrued interestFair value / carrying value
Private investments and unlisted equities$27,570$49,902$(5,206)$—$72,266
Debt and convertible debt securities2,713—(1,510)901,293
Total other investments$30,283$49,902$(6,716)$90$73,559

At December 31, 2023, the breakdown of the Company’s other investments was as follows:

CostUnrealizedgainsUnrealizedlossesAccrued interestFair value / carrying value
Private investments and unlisted equities$28,470$49,424$(6,737)$—$71,157
Debt and convertible debt securities2,499—(499)1362,136
Total other investments$30,969$49,424$(7,236)$136$73,293

The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2024 and 2023, and the related adjustments recorded during the periods then ended.

20242023
Carrying value (1)$72,266$64,849
Upward carrying value changes (2)$501$506
Downward carrying value changes and impairment (3)$—$(2,780)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.

(2)The cumulative upward carrying value changes from inception to September 30, 2024, totaled $50.9 million.

(3) The cumulative downward carrying value changes and impairments from inception to September 30, 2024, totaled $2.8 million.

Net investment income

The following table summarizes the change in unrealized gains (losses) and the realized gains (losses) for the Company’s other investments, which are included in “Net investment income” in the condensed consolidated statements of operations (see Note 13):

Three months ended September 30Nine months ended September 30
2024202320242023
Gross realized gains$—$—$—$—
Gross realized losses——(1,332)(800)
Net realized gains (losses)$—$—$(1,332)$(800)
Change in unrealized gains—(2,555)1,008(1,499)
Net realized and unrealized gains (losses) on other investments$—$(2,555)$(324)$(2,299)

During the nine months ended September 30, 2024, the Company collected $0.2 million of liquidation proceeds relating to a private investment which was previously fully impaired, resulting in a gross realized loss of $1.3 million offset by a corresponding reduction in unrealized losses of $1.5 million. The Company also impaired $1.1 million of convertible debt securities, offset partially by favorable adjustment to the carrying value of a private investment as a result of a completed financing round by the investee.

During the three and nine months ended September 30, 2023, the Company realized a loss of $nil and $0.8 million, respectively, and a corresponding reversal of unrealized loss relating to an investment which was previously fully impaired at December 31, 2022, resulting in no impact to the Company’s net income (loss). Additionally, for the same periods, the Company recognized $2.6 million of unrealized losses on certain investments as a result of completed financing rounds by such investees.

  1. RESTRICTED CASH AND CASH EQUIVALENTS

The following table shows the breakdown of the Company’s restricted cash and cash equivalents, along with a reconciliation of the total cash, cash equivalents, and restricted cash reported in the condensed consolidated statements of cash flows:

September 30, 2024December 31, 2023
Restricted cash and cash equivalents:
Cash securing trust accounts$267,066$300,152
Cash securing letters of credit issued285,775291,456
Cash securing Loan Facility10,00010,000
Other4,2503,040
Total restricted cash and cash equivalents567,091604,648
Cash and cash equivalents54,64251,082
Total cash, cash equivalents, and restricted cash$621,733$655,730
  1. FAIR VALUE MEASUREMENTS

Assets measured at fair value on a nonrecurring basis

At September 30, 2024 and December 31, 2023, the Company held $61.8 million and $61.3 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. At September 30, 2024, the Company held $10.4 million (2023: $9.9 million) of private investments and unlisted equities measured at cost. The Company classifies these investments as Level 3 within the fair value hierarchy.

The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2024, for the private and unlisted equities measured at fair value on a nonrecurring basis:

Less than 6 months6 to 12 monthsOver 1 yearTotal
Fair values measured on a nonrecurring basis$12,434$7,190$42,223$61,847

Assets measured at fair value on a recurring basis

Derivative financial instruments

The Company uses interest rate swaps in connection with its risk management activities to hedge 50% of the interest rate risk relating to the outstanding Term Loans (see Note 9). The interest rate swaps are carried at fair value and are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors. Accordingly, the interest rates swaps are classified as Level 2 within the fair value hierarchy. These derivative instruments are not designated as accounting hedges under U.S. GAAP.

For the three and nine months ended September 30, 2024, the Company recognized an unrealized loss for the above derivatives of $0.6 million and $0.1 million, respectively, which is included in interest expense in the condensed consolidated statements of operations. The unrealized loss for the nine months ended September 30, 2024, is reported as “net change in unrealized gains and losses on investments and derivatives” in the condensed consolidated statements of cash flows. The derivative liability is included in other liabilities in the condensed consolidated balance sheets.

Financial Instruments Disclosed, But Not Carried, at Fair Value

At September 30, 2024, the carrying value of debt and convertible debt securities within “Other Investments” (see Note 4) and the Term Loans approximates their fair values. The Company classifies these financial instruments as Level 2 within the fair value hierarchy.

  1. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:

September 30, 2024December 31, 2023
Case reserves$216,200$189,050
IBNR594,952472,504
Total$811,152$661,554

Reserve Roll-forward

The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:

ConsolidatedNine months ended September 30
20242023
Gross balance at January 1$661,554$555,468
Less: Losses recoverable(25,687)(13,239)
Net balance at January 1635,867542,229
Incurred losses related to:
Current year305,467273,570
Prior years(943)10,502
Total incurred304,524284,072
Paid losses related to:
Current year(27,382)(41,026)
Prior years(176,210)(154,374)
Total paid(203,592)(195,400)
Foreign currency revaluation8,405(858)
Net balance at September 30745,205630,043
Add: Losses recoverable (see Note 8)65,94728,191
Gross balance at September 30$811,152$658,234

Estimates for Significant Catastrophe Events

At September 30, 2024, the Company’s net reserves for losses and loss expenses include estimated amounts for several catastrophe and weather-related events (“CAT loss”). The magnitude and volume of losses arising from these events is inherently uncertain and, consequently, actual losses for these events may ultimately differ, potentially materially, from current estimates.

During the nine months ended September 30, 2024, the Company recognized total CAT loss, net of reinsurance, of $48.9 million. Current year CAT loss events were $39.9 million, driven mainly by the Baltimore Bridge collapse, Hurricane Helene, and U.S. tornados (including severe convective storms). Additionally, the Company incurred $9.0 million of net adverse prior year CAT loss development relating primarily to U.S. tornados (including severe convective storms) affecting U.S. homeowners’ property coverage (2021-2023 underwriting years).

During the nine months ended September 30, 2023, the Company recognized total CAT loss, net of reinsurance, of $20.2 million. Current year CAT loss events were $29.5 million, driven mainly by the Turkey earthquake, New Zealand Cyclone Gabrielle and U.S. tornados, coupled with $9.3 million net favorable prior year CAT loss development predominantly from various prior years’ property catastrophe events (mostly 2019, 2021 and 2022 underwriting years).

Prior Year Reserve Development

During the nine months ended September 30, 2024, the Company experienced $0.9 million in net favorable development on prior year loss and LAE reserves. This was comprised of $11.4 million of favorable loss development predominantly from mortgage contracts (various underwriting years), general liability treaties (mostly 2021-2022 underwriting years), multiline commercial (predominantly 2020 underwriting year) and other specialty business (mostly 2020-2023 underwriting years). This was partially offset by $10.5 million of reserve strengthening predominantly for prior years’ CAT loss events mentioned above.

During the nine months ended September 30, 2023, the Company experienced $10.5 million in net adverse development on prior year loss and LAE reserves. This was comprised of $31.3 million of reserve strengthening predominantly on legacy motor (mainly 2021 underwriting year) and workers’ compensation (2021 and prior underwriting years) due to current economic and social inflation trends, coupled with adverse CAT loss development on U.S. homeowners’ property business relating to Winter Storm Elliott (2022 underwriting year) and a final claim settlement on a professional liability contract (2008 underwriting year). This was partially offset by $20.8 million better than expected loss emergence predominantly from the above prior years’ CAT loss events, marine and energy (predominantly 2020 and 2022 underwriting years), group medical (2022 and prior underwriting years), and cyber contracts (predominantly 2021 underwriting year).

  1. RETROCESSION

The following table provides a breakdown of ceded reinsurance:

Three months ended September 30Nine months ended September 30
2024202320242023
Gross ceded premiums$26,598$14,789$64,611$35,740
Earned ceded premiums$19,512$15,318$46,603$35,195
Loss and loss adjustment expenses ceded$10,070$9,086$47,919$24,794

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. The following table shows a breakdown of losses recoverable on a gross and net of collateral basis:

September 30, 2024 · December 31, 2023
Gross · Net of Collateral(1) · Gross · Net of Collateral(1)
A- or better by A.M. Best$40,028$40,028$8,767$8,767
Not rated26,6197,23917,4072,432
Total before provision66,647$47,267$26,174$11,199
Provision for credit losses(700)(487)
Total loss and loss adjustment expenses recoverable, net$65,947$25,687

(1) Collateral is in the form of cash, letters of credit, funds withheld, and/or cash collateral held in trust accounts. This excludes any excess collateral in order to disclose the aggregate net exposure for each retrocessionaire.

At September 30, 2024, we had 3 reinsurers (December 31, 2023: 3) that accounted for 10% or more of the total loss and loss adjustment expenses recoverable, net of the credit loss provision, for an aggregate gross amount of $46.1 million (December 31, 2023: $20.4 million).

  1. DEBT AND CREDIT FACILITIES

Debt Obligations

The following table summarizes the Company’s outstanding debt obligations.

September 30, 2024December 31, 2023
Term loans$62,187$74,062
Accrued interest payable951—
Less: deferred financing costs(556)(781)
Total debt$62,582$73,281

During the nine months ended September 30, 2024, the Company partially repaid $11.9 million of the outstanding Term loans.

Credit Facilities

At September 30, 2024, the Company had the following letter of credit (“LOC”) facilities:

CapacityLOCs issuedTermination Date
Citibank Europe plc ("Citi LOC")$229,752$229,752August 20, 2024
CIBC Bank USA ("CIBC LOC")200,00055,969December 21, 2024
$429,752$285,721

The above LOCs issued are cash collateralized (see Note 5). The LOC facilities are subject to various customary affirmative, negative and financial covenants. At September 30, 2024, the Company was in compliance with all LOC facilities covenants.

On August 20, 2024, the $275 million committed capacity under the Citi LOC agreement was terminated, but continues to be in effect on an uncommitted basis.

  1. SHARE CAPITAL

Ordinary Shares

The following table is a summary of changes in ordinary shares issued and outstanding for the nine months ended September 30, 2024 and 2023:

2024 · 2023
OrdinaryOrdinaryClass AClass B
Balance – beginning of period35,336,732—28,569,3466,254,715
Issue of shares, net of forfeitures43,16365,394447,952—
Repurchase of shares(547,402)———
Re-designate Class B to Class A shares——6,254,715(6,254,715)
Reclassify Class A to Ordinary shares—35,272,013(35,272,013)—
Balance – end of period34,832,49335,337,407——

The Company’s authorized share capital is 125,000,000 ordinary shares, par value of $0.10 per share.

On July 25, 2023, at the Company’s Annual General Meeting the shareholders approved the re-designation of Class B ordinary shares as Class A ordinary shares, and then reclassified Class A ordinary shares as “ordinary shares”, resulting in the elimination of the dual-class share structure.

At September 30, 2024, the Company has an effective Form S-3 registration statement on file with the SEC for an aggregate principal amount of $200.0 million in securities.

Share Repurchase Plan

On May 3, 2024, the Board of Directors re-approved the share repurchase plan, until June 30, 2025, authorizing the Company to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. Any shares repurchased are canceled immediately upon repurchase. For the three and nine months ended September 30, 2024, the Company repurchased 547,402 ordinary shares for $7.5 million.

Preferred Shares

The Company’s authorized share capital also consists of 50,000,000 preference shares with a par value of $0.10 each. At September 30, 2024, the Company has no issued and outstanding preferred shares.

  1. SHARE-BASED COMPENSATION

Refer to Note 11 of the Company’s audited consolidated financial statements of its 2023 Form 10-K for a summary of the Company’s 2023 Incentive Plan, including the definition of performance-based and service-based stock awards.

Employee and Director Restricted Shares

The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the nine months ended September 30, 2024 and 2023:

Performance Restricted SharesService Restricted Shares
Number ofnon-vestedrestricted sharesWeighted averagegrant datefair valueNumber ofnon-vestedrestricted sharesWeighted averagegrant datefair value
Balance at December 31, 2022794,362$7.62832,896$7.76
Granted357,7669.85242,95710.22
Vested——(364,006)6.96
Forfeited(109,105)9.37(55,967)8.43
Balance at September 30, 20231,043,023$8.20655,880$9.05
Balance at December 31, 20231,042,688$9.94419,604$9.18
Granted——58,75112.51
Vested——(282,916)9.35
Forfeited(89,945)10.84——
Balance at September 30, 2024952,743$9.86195,439$9.93

At September 30, 2024,2,825,659 (December 31, 2023:3,296,771) ordinary shares remained available for future issuance under the Company’s 2023 Incentive Plan.

During the nine months ended September 30, 2024 , the Company grantedno RSs to employees and 58,751 RSs to non-employee directors as part of their remuneration for services to the Company (2023:535,329 RSs to employees and non-employee directors). These will vest on the earlier of (1) the first anniversary of the date of the share issuance and (ii) the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. During the vesting period, non-employee directors retain voting rights on these RSs; but they are not entitled to any dividends declared until the RSs vest.

For the nine months ended September 30, 2024, the total fair value of Service RSs vested was $2.6 million (2023: $2.5 million).

Employee Restricted Stock Units

The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the nine months ended September 30, 2024 and 2023:

Performance RSUsService RSUs
Number ofnon-vestedRSUsWeighted averagegrant datefair valueNumber ofnon-vestedRSUsWeighted averagegrant datefair value
Balance at December 31, 2022105,008$6.82172,952$7.58
Granted71,1219.8542,8119.85
Vested——(77,695)6.74
Forfeited——(1,788)7.82
Balance at September 30, 2023176,129$8.04136,280$8.76
Balance at December 31, 2023154,445$8.03110,425$8.78
Granted258,14811.85124,42511.85
Vested——(74,357)8.84
Forfeited(6,229)9.15(5,806)10.67
Balance at September 30, 2024406,364$10.44154,687$11.15

For the awards granted during the nine months ended September 30, 2024, the Service RSUs vest evenly over three years on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of athree-year performance period within a range of 50% and 200% of the awarded Performance RSUs, with a target of 100%.

For the nine months ended September 30, 2024, the total fair value of Service RSUs vested was $0.7 million (2023: $0.5 million).

Employee and Director Stock Options

During the nine months ended September 30, 2024,250,000 ordinary share purchase options were granted to the Company’s CEO, pursuant to his employment contract. These options vest 50,000 annually and expire in 10 years from the grant date. The grant date fair value of these options was $4.31 per share, based on the Black-Scholes option pricing model. The following inputs were used in this pricing model:

Expected volatility36.4%
Expected term (in years)5
Expected dividend yield—%
Risk-free interest rate3.9%
Stock price at grant date$11.20

Stock Compensation Expense

For the nine months ended September 30, 2024 and 2023, the Company recorded $4.6 million and $3.5 million of total stock compensation expense (net of forfeitures), respectively. The stock compensation expense is included in “General and administrative expenses” in the condensed consolidated statements of operations. Forfeiture recoveries were immaterial for both periods.

  1. EARNINGS PER SHARE

The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and nine months ended September 30, 2024 and 2023:

Three months ended September 30Nine months ended September 30
2024202320242023
Numerator for EPS
Net income - basic$35,237$13,477$70,234$69,224
Net income - diluted$35,237$13,477$70,234$69,224
Denominator for EPS
Weighted average shares outstanding - basic34,120,95534,070,81834,210,56034,067,012
Effect of dilutive employee and director share-based awards689,111731,046613,812636,961
Weighted average shares outstanding - diluted34,810,06634,801,86434,824,37234,703,973
Anti-dilutive stock options outstanding870,319652,140870,319652,140
EPS:
Basic$1.03$0.40$2.05$2.03
Diluted$1.01$0.39$2.02$1.99
  1. NET INVESTMENT INCOME

The following table provides a breakdown of net investment income:

Three months ended September 30Nine months ended September 30
2024202320242023
Interest and dividend income, net of withholding taxes and other expenses$8,244$9,513$24,935$27,004
Net realized and unrealized gains on other investments (see Note 4)—(2,555)(324)(2,299)
Net investment-related income8,2446,95824,61124,705
Share of Solasglas' net income (loss) (see Note 3)19,844(1,853)42,42227,791
Total investment income$28,088$5,105$67,033$52,496
  1. RELATED PARTY TRANSACTIONS

Investment Advisory Agreement

There has been no change to the Company’s investment advisory agreement with Solasglas as described in its 2023 Form 10-K. Refer to Note 3 for a breakdown of management fees and performance fees for the nine months ended September 30, 2024 and 2023.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2024, Solasglas, along with certain affiliates of DME Advisors, collectively owned 23.0% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in Solasglas. At September 30, 2024, Solasglas held 1.3 million shares of GRBK.

Service Agreement

The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation offive thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party.

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the Solasglas LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.

  1. COMMITMENTS AND CONTINGENCIES

a) Concentration of Credit Risk

Cash and cash equivalents

The Company monitors its concentration of credit risk with financial institutions and limits acceptable counterparties based on current rating, outlook and other relevant factors.

Investments

The Company’s credit risk exposure to private debt and convertible debt securities within its “Other investments” are immaterial (see Note 4).

Reinsurance balances receivable, net

The following table shows the breakdown of reinsurance balances receivable:

September 30, 2024December 31, 2023
Amount%Amount%
Premiums receivable$259,23536.1%$186,94030.2%
Funds withheld:
Funds held by cedants51,3327.1%50,0758.1%
Premiums held by Lloyds' syndicates296,15241.2%264,27842.7%
Funds at Lloyd’s110,39515.4%115,77218.6%
Profit commission receivable2,4700.3%2,3020.4%
Deposit assets——%8880.1%
Total before provision719,584100.1%620,255100.1%
Provision for expected credit losses(865)(0.1)%(854)(0.1)%
Reinsurance balances receivable, net$718,719100.0%$619,401100.0%

The Company has posted deposits at Lloyd’s to support underwriting capacity for certain syndicates, including Syndicate 3456. Lloyd’s has a credit rating of “A+” (Superior) from A.M. Best, as revised in August 2024.

Premiums receivable includes a significant portion of estimated premiums not yet due. Brokers and other intermediaries are responsible for collecting premiums from customers on the Company’s behalf. The Company monitors its concentration of credit risks from brokers. The diversity in the Company’s client base limits credit risk associated with premiums receivable and funds (premiums) held by cedents. Further, under the reinsurance contracts the Company has contractual rights to offset premium balances receivable and funds held by cedants against corresponding payments for losses and loss expenses.

Loss and loss adjustment expenses recoverable, net

The Company regularly evaluates its net credit exposure to the retrocessionaires and their abilities to honor their respective obligations. See Note 8 for analysis of concentration of credit risk relating to retrocessionaires.

b) Lease Obligations

There was no material change to the Company’s operating lease agreements subsequent to its 2023 Form 10-K.

c) Litigation

From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.

  1. SEGMENT REPORTING

The Company hasone operating segment: Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business

Three months ended September 30 · Nine months ended September 30
2024 · 2023 · 2024 · 2023
Property
Commercial$14,7948.8%$16,1058.8%$45,0308.0%$45,2368.6%
Motor1890.11220.13440.17060.1
Personal(1,358)(0.8)16,7139.116,2042.948,7189.3
Total Property13,6258.132,94018.061,57811.094,66018.0
Casualty
General Liability28,08416.731,32517.183,48215.179,40115.1
Motor Liability2,9001.72,9171.617,5563.211,2232.1
Professional Liability (1)33—1,6250.9152—4,8500.9
Workers' Compensation9390.64,4842.44,3190.811,5422.2
Multi-line (1)60,16835.768,61337.5173,60931.3177,54433.9
Total Casualty92,12454.7108,96459.5279,11850.4284,56054.2
Other
Accident & Health2,3291.41,6950.96,2071.16,1841.2
Financial11,8687.017,0599.350,0129.048,4069.2
Marine11,2006.73,9732.241,6427.523,9674.6
Other Specialty37,20022.118,44310.1116,02221.066,69512.8
Total Other62,59737.241,17022.5213,88338.6145,25227.8
$168,346100.0%$183,074100.0%$554,579100.0%$524,472100.0%

(1) For the 2023 comparative periods, the Company has reclassified one treaty from Professional Liability to Multi-Line to conform with the current presentation within Casualty.

Gross Premiums Written by Geographic Area of Risks Insured

Three months ended September 30 · Nine months ended September 30
2024 · 2023 · 2024 · 2023
U.S. and Caribbean$54,35932.3%$77,27442.2%$173,51931.3%$206,71439.4%
Worldwide (1)102,57360.988,03748.1337,03560.8269,43051.4
Europe1,6871.01,8681.09,9671.88,9361.7
Asia9,7275.815,8958.734,0586.139,3927.5
$168,346100.0%$183,074100.0%$554,579100.0%$524,472100.0%

(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.

  1. SUBSEQUENT EVENTS

In October 2024, Hurricane Milton made landfall on the west coast of Florida. The Company’s preliminary loss estimates related to this event is in the range of $5.0 million to $15.0 million, based upon currently available information such as industry loss estimates and a high-level review of our in-force contracts. The Company will refine its estimated loss for Hurricane Milton, which will be recorded in the fourth quarter of 2024, as additional details about the event and actual level of claims emerge.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.